Cargando…

Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents

Intravitreal injection of anti-vascular endothelial growth factor is currently the preferred treatment for several posterior segment diseases, including age-related macular degeneration and diabetic retinopathy, as well as macular edema and retinal vein occlusion. As an invasive procedure it involve...

Descripción completa

Detalles Bibliográficos
Autores principales: Labardini, Cecilia P., Blumenthal, Eytan Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rambam Health Care Campus 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185999/
https://www.ncbi.nlm.nih.gov/pubmed/30180932
http://dx.doi.org/10.5041/RMMJ.10348
_version_ 1783362787414638592
author Labardini, Cecilia P.
Blumenthal, Eytan Z.
author_facet Labardini, Cecilia P.
Blumenthal, Eytan Z.
author_sort Labardini, Cecilia P.
collection PubMed
description Intravitreal injection of anti-vascular endothelial growth factor is currently the preferred treatment for several posterior segment diseases, including age-related macular degeneration and diabetic retinopathy, as well as macular edema and retinal vein occlusion. As an invasive procedure it involves risks. The most significant risk is infectious endophthalmitis, a sight-threatening and even a globe-threatening acute fulminant condition. Most common pathogens include Streptococcus and Staphylococcus species, surprisingly originating from the patient’s, surgeon’s, or nurse’s mouth. Infectious endophthalmitis may have devastating and irreversible effect, with Streptococcus-induced cases having the worst visual outcome. It is therefore crucial for clinicians to promptly recognize and treat such conditions, and, far more important, to put in place protective and preventive measures against this rare, but sight-threatening complication. To that end, this paper describes the most common pathogens causing endophthalmitis after IVI of anti-VEGF, and defines their source, to aid the physician in developing strategies to prevent this catastrophic infection.
format Online
Article
Text
id pubmed-6185999
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Rambam Health Care Campus
record_format MEDLINE/PubMed
spelling pubmed-61859992018-10-22 Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents Labardini, Cecilia P. Blumenthal, Eytan Z. Rambam Maimonides Med J Special Issue Celebrating the 80th Anniversary of Rambam Health Care Campus Intravitreal injection of anti-vascular endothelial growth factor is currently the preferred treatment for several posterior segment diseases, including age-related macular degeneration and diabetic retinopathy, as well as macular edema and retinal vein occlusion. As an invasive procedure it involves risks. The most significant risk is infectious endophthalmitis, a sight-threatening and even a globe-threatening acute fulminant condition. Most common pathogens include Streptococcus and Staphylococcus species, surprisingly originating from the patient’s, surgeon’s, or nurse’s mouth. Infectious endophthalmitis may have devastating and irreversible effect, with Streptococcus-induced cases having the worst visual outcome. It is therefore crucial for clinicians to promptly recognize and treat such conditions, and, far more important, to put in place protective and preventive measures against this rare, but sight-threatening complication. To that end, this paper describes the most common pathogens causing endophthalmitis after IVI of anti-VEGF, and defines their source, to aid the physician in developing strategies to prevent this catastrophic infection. Rambam Health Care Campus 2018-10-04 /pmc/articles/PMC6185999/ /pubmed/30180932 http://dx.doi.org/10.5041/RMMJ.10348 Text en Copyright: © 2018 Labardini and Blumenthal. This is an open-access article. All its content, except where otherwise noted, is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Issue Celebrating the 80th Anniversary of Rambam Health Care Campus
Labardini, Cecilia P.
Blumenthal, Eytan Z.
Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
title Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
title_full Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
title_fullStr Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
title_full_unstemmed Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
title_short Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
title_sort causative pathogens in endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents
topic Special Issue Celebrating the 80th Anniversary of Rambam Health Care Campus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185999/
https://www.ncbi.nlm.nih.gov/pubmed/30180932
http://dx.doi.org/10.5041/RMMJ.10348
work_keys_str_mv AT labardiniceciliap causativepathogensinendophthalmitisafterintravitrealinjectionofantivascularendothelialgrowthfactoragents
AT blumenthaleytanz causativepathogensinendophthalmitisafterintravitrealinjectionofantivascularendothelialgrowthfactoragents